Related Experiment Video

Updated: May 20, 2026

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
11:19

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices

Published on: May 10, 2020

[Magnesium metabolism and therapeutic strategy in cardiovascular disease]

Kenji Hoshino1

  • 1Pediatric cardiology, Saitama Children's Medical Center, Japan.

Clinical Calcium
|August 1, 2012
PubMed

Insights

Magnesium (Mg) deficiency is linked to cardiovascular diseases like heart attack and arrhythmias. Supplementation may offer cardioprotective benefits and manage heart failure, though more research is needed.

Area of Science:

  • Cardiology
  • Biochemistry
  • Epidemiology

Context:

  • Epidemiological and clinical studies indicate a significant association between magnesium levels and cardiovascular disease.
  • Hypomagnesemia (low magnesium) is implicated in various cardiac conditions, including ischemic heart disease and post-surgical arrhythmias.
  • The role of magnesium in congestive heart failure and its potential for negative feedback loops are also noted.

Purpose:

  • To analyze the precise actions of magnesium in cardiovascular disease.
  • To explore the therapeutic potential of magnesium in managing cardiac conditions.
  • To clarify the complex relationship between magnesium metabolism and cardiovascular health.

Summary:

  • Low magnesium levels may trigger ischemic heart disease, arrhythmias post-cardiac surgery, and Torsades de Pointes (TdP).
  • Magnesium infusion has shown potential in reducing mortality from acute myocardial infarction and offering cardioprotective effects, though this remains debated.
  • Therapeutic magnesium is reported to decrease post-surgery arrhythmias, terminate TdP, and improve outcomes in congestive heart failure.

Impact:

  • Highlights the critical role of magnesium in cardiovascular health and disease.
  • Suggests magnesium therapy as a potential treatment for various cardiac arrhythmias and heart failure.
  • Underscores the need for further research into magnesium's mechanisms and clinical applications in cardiology.

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...